書籍詳細

Chapter1 脳と脳血管の解剖・生理

P.41 掲載の参考文献

• 1) 篠原治道, 古林秀則 : 中枢神経系解剖実習の要点, 最新医学社, 2003

• 2) Brodal P : The central nervous system, structure and function, 3rd edition, Oxford university press, 2004

• 3) Brodmann K : Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grunddes Zellenbaues, JA Barth, Leipzig, 1909

• 4) 遠山正彌編 : 分子脳・神経機能解剖学, 金芳堂, 京都, 2004

• 5) Penfield W, Rasmussen T : The cerebral cortex of man, Macmillan, New York, 1950

• 6) 藤木稔, 古林秀則 : 経皮磁気刺激による脳機能マッピング. 先端医療シリーズ脳神経外科の最新医療 (菊地晴彦編), 先端医療技術研究所, 東京, 2004, p.252-256

• 7) 森墾, 増谷佳孝, 青木茂樹ほか : tractographyによる皮質脊髄路描出法の比較検討;one-ROI法とtwo-ROI法. Nippon, Act Radiol 63 : 51-53, 2003

• 8) Kimura J : Electrodiagnosis in diseases of nerve and muscle : principle and practice, FA Davis, Philadelphia, 1983

P.52 掲載の参考文献

• 1) Korogi Y, Takahashi M, Nakagawa T et al : Intracranial vascular stenosis and occlusion : MR angiographic findings. AJNR Am J Neuroradiol 18 : 135-143, 1997
  pubmed

• 2) 寺尾心一, 武田明夫, 祖父江元 : 一過性黒内障. 別冊日本臨床神経症候群I 26 : 172-175, 1999

• 3) Alpers BJ, Berry RG : Circle of Willis in cerebral vascular disorders. The anatomical structure. Arch Neurol 8 : 398-402, 1963
  pubmed

• 4) Haverling M : The tortuous basilar artery. Acta Radiol Diagn (Stockh) 15 : 241-249, 1974
  pubmed

• 5) 田崎義昭, 斎藤佳雄 : 脳血管の閉塞部位と臨床症候. ベッドサイドの神経の診かた改訂16版, 南山堂, 東京, 2004, p.367-369

• 6) Smith CG, Richardson WF : The course and distribution of the arteries supplying the visual (striate) cortex. Am J Ophthalmol 61 : 1391-96, 1966
  pubmed

• 7) Kretschmann HJ, Weinrich W (久留裕, 真柳佳昭訳) : 脳動脈と支配領域, 脳静脈. 画像診断のための脳解剖と機能系, 医学書院, 東京, 1995, p.191-216

P.61 掲載の参考文献

• 1) 藤井健一郎, 藤島正敏 : 脳循環と代謝のcoupling. Clinical Nezaroscience 6 : 737-739, 1988

• 2) 藤井健一郎, 藤島正敏 : 高血圧と脳循環-その臨床的意義-. Medical Practice 5 : 2045-2049, 1988

• 3) Fujishima M, Ibayashi S, Fujii K et al : Physiology of cerebral blood flow and theory of its measurement. Tomonaga M, Tanaka A, Yonas H eds., Quantitative cerebral blood flow measurements using stable Xenon/CT : clinical applications, Armonk, NY, Futura Publishinig Co. Inc., 1995, p.11-25

• 4) 藤井健一郎, 藤島正敏 : 危険因子による脳循環変化と脳卒中-高血圧症-. 脳と循環 1 : 133-138, 1996

• 5) 藤井健一郎 : 脳虚血の病態生理-脳循環代謝を中心に-. 麻酔と蘇生 32 : 37-39, 1996

Chapter2 脳卒中の病態

P.70 掲載の参考文献

• 1) Ad Hoc Committee on cerebrovascular disease of NINDB : A classification and outline of cerebrovascular disease. Neurology 8 : 1-34, 1958

• 2) National Institute of Neurological Disorders and Stroke Ad Hoc Committee : Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular disease III. Stroke 21 : 637-676, 1990

• 3) 峰松一夫 : 脳血管障害の定義と分類. 日常診療の為の脳血管障害シリーズI;脳血管障害の成因 (矢崎義雄監), 現代医療社, 東京, 1998, p.3-14

• 4) 平井俊策 : 脳の動脈硬化性疾患の定義および診断基準に関する研究. 平成元年度厚生省循環器病研究委託費による研究報告集. 国立循環器病センター, 1990, p.80

• 5) Inatomi Y, Kimura K, Yonehara T et al : DWI abnormalities and clinicalcharacteristics in TIA patients. Neurology 62 : 376-380, 2004

• 6) Albers GW, Caplan LR, Easton JD et al : Transient ischemic attack-proposal for a new definition. N Engl J Med 21 : 1713-1716, 2002
  pubmed

• 7) Ueda K, Kiyohara Y, Hasuo Y et al : Transient cerebral ischemic attacks in a Japanese community, Hisayama, Japan. Stroke 18 : 844-848, 1987

• 8) Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association : Guidelines for the management of transient ischemic attacks. Stroke 25 : 1320-1335, 1994

• 9) 佐渡島省三, 清原裕;脳出血のrisk factor. Clinical Neuroscience 12 : 1332-1335, 1994

• 10) Ueda K, Hasuo Y, Kiyohara Y et al : Intracerebral hemorrhage in a Japanese community, Hisayama : incidence, changing pattern during long-term follow-up, and related factors. Stroke 19 : 48-52, 1988

• 11) van Gijn J, Rinkel GJ : Subarachnoid haemorrhage : diagnosis, causes and management. Brain 124 : 249-278, 2001
  pubmed

• 12) Mayberg MR, Batjer HH, Dacey R et al : Guidelines for themanagement of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25 : 2315-2328, 1994

• 13) Graf CJ, Perret GE, Torner JC : Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 58 : 331-337, 1983
  pubmed

• 14) Mast H, Young WL Koennecke HC, et al : Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet 350 : 1065-1068, 1997
  pubmed

• 15) 峰松一夫, 山口武典ほか : 循環器疾患の治療指針 (国立循環器病センター編), 1997, p.189-211

• 16) Minematsu K, Yamaguchi T, Omae T : ‘Spectacular shrinking deficit' : rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 42 : 157-162, 1992

• 17) Okada Y, Yamaguchi T, Minematsu K et al : Hemorrhagic transformation in cerebral embolism. Stroke 20 : 598-603, 1989
  pubmed

• 18) Irie K, Yamaguchi T, Minematsu K et al : The J-curve phenomenon in stroke recurrence. Stroke 24 : 1844-1849, 1993

• 19) Toyoda K, Yasaka M, Nagata S et al : Aortogenic embolic stroke : a transesophageal echocardiographic approach. Stroke 23 : 1056-1061, 1992
  pubmed

P.79 掲載の参考文献

• 1) Fisher CM : Lacunes : small, deep cerebral infarcts. Neurology 15 : 774-784, 1965
  pubmed

• 2) Fisher CM : Ataxic hemiparesis. A pathologic study. Arch Neurol 35 : 126-128, 1978
  pubmed

• 3) Tuszynski MH, Petito CK, Levy DE : Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke 20 : 990-999, 1989
  pubmed

• 4) Mohr JP, Kase CS, Meckler RJ et al : Sensorimotor stroke due to thalamocapsular ischemia. Arch Neurol 34 : 739-741, 1977
  pubmed

• 5) Fisher CM : Lacunar strokes and infarcts : a review. Neurology 32 : 871-876, 1982
  pubmed

• 6) Chamorro A, Sacco RL, Mohr JP et al : Clinical-computed tomographic correlations of lacunar infarction in the Stroke Data Bank. Stroke 22 : 175-181, 1991
  pubmed

• 7) Gan R, Sacco RL, Kargman DE et al : Testing the validity of the lacunar hypothesis : the Northern Manhattan Stroke Study experience. Neurology 48 : 1204-1211, 1997
  pubmed

• 8) Adams HP Jr, Bendixen BH, Kappelle LJ et al : Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke24 : 35-41, 1993

• 9) Lee LJ, Kidwell CS, Alger J et al : Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31 : 1081-1089, 2000
  pubmed

• 10) Wessels T, Rottger C, Jauss M et al : Identification of embolic stroke patterns by diffusion-weighted MRI inclinically defined lacunar stroke syndromes. Stroke 36 : 757-761, 2005
  pubmed

• 11) Jackson C, Sudlow C : Are lacunar strokes reallydifferent? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts. Stroke 36 : 891-901, 2005
  pubmed

• 12) Macdonald RL, Kowalczuk A, Johns L : Emboli enter penetrating arteries of monkey brain in relation to their size. Stroke 26 : 1247-1250, 1995
  pubmed

• 13) Futrell N : Lacunar infarction : embolism is the key. Stroke 35 : 1778-1779, 2004
  pubmed

• 14) Inzitari D, Eliasziw M, Sharpe BL et al : Risk factors and outcome of patients with carotid artery stenosis presenting with lacunar stroke. North American Symptomatic Carotid Endarterectomy Trial Group.Neurology 54 : 660-666, 2000
  pubmed

• 15) Kazui S, Levi CR, Jones EF et al : Risk factors for lacunar stroke : a case-control transesophageal echocardiographic study. Neurology 54 : 1385-1387, 2000

• 16) Wardlaw JM, Dennis MS, Warlow CP et al : Imaging appearance of the symptomatic perforating artery in patients with lacunar infarction : occlusion or other vascular pathology? Ann Neurol 50 : 208-215, 2001
  pubmed

• 17) Hassan A, Hunt BJ, O'Sullivan M et al : Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 126 : 424-432, 2003
  pubmed

• 18) Wardlaw JM, Sandercock PA, Dennis MS et al : Isbreakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34 : 806-812, 2003
  pubmed

• 19) Steinke W, Ley SC : Lacunar stroke is the major cause of progressive motor deficits. Stroke 33 : 1510-1516, 2002
  pubmed

• 20) Marinkovic SV, Milisavljevic MM, Kovacevic MS et al : Perforating branches of the middle cerebral artery. Microanatomy and clinical significance of their intracerebral segments. Stroke 16 : 1022-1029, 1985
  pubmed

• 21) Takao M, Koto A, Tanahashi N et al : Pathologic findings of silent, small hyperintense foci in the basal ganglia and thalamus on MRI. Neurology 52 : 666-668, 1999
  pubmed

• 22) 卜蔵浩和, 小林祥泰, 山口修平ほか : MRIにおける潜在性脳血管障害の分類とその危険因子に関する検討. 脳卒中 17 : 292-297, 1995

• 23) Fan YH, Mok VC, Lam WW et al : Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts. J Neurol 251 : 537-541, 2004
  pubmed

P.87 掲載の参考文献

• 1) 岡田靖 : 脳卒中治療ガイドライン2004-内科医からみたコンセンサス-5. 頸動脈狭窄の治療指針. 脳と神経 56 : 941-949, 2004

• 2) 大坪亮一, 岡田靖 : アテローム血栓性脳梗塞. 脳卒中の画像診断 (山口武典, 橋本信夫編), 中外医学社, 東京, 1998, p.179-191

• 3) Grubb RL Jr, Derdeyn CP, Fritsch SM et al : Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 280 : 1055-1060, 1998
  pubmed

• 4) Handa N, Matsumoto M, Maeda H et al : Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis (the OSACA study). Stroke 26 : 1781-1786, 1995
  pubmed

• 5) Shimada T, Toyoda K, Inoue T et al : Prediction of coronary artery disease in patients undergoing carotid endarterectomy. J Neurosurg 103 : 593-596, 2005
  pubmed

• 6) 藤本茂, 岸川和裕, 岡田靖 : 脳血管障害の最先端診療2 : 頸動脈高度狭窄の超音波診断の意義. 医療 57 : 135-140, 2003

• 7) 藤本茂, 岡田靖 : 脳血管障害の最先端診療3 : 脳血管障害における経頭蓋カラードプラの臨床的意義. 医療 57 : 214-220, 2003

• 8) 藤本茂, 岡田靖 : 脳梗塞の予知・予防策の充実6頸動脈病変. 治療学 37 : 898-902, 2003

• 9) Antithrombotic Trialists'Collaboration : Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71-86, 2002
  pubmed

• 10) Hankey GJ, Sudlow CL, Dunbabin DW : Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 31 : 1779-1784, 2000

• 11) North American Symptomatic Carotid Endarterectomy Trial Collaborators : Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 : 445-453, 1991
  pubmed

• 12) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 : 1421-1428, 1995
  pubmed

• 13) JET Study Group : Japanese EC-IC Trial (JET Study) : study designと中間解析結果. 脳卒中の外科 30 : 97-100, 2002

P.99 掲載の参考文献

• 1) 山口武典監, 峰松一夫, 由谷親夫編 : 心原性脳塞栓症, 医学書院, 東京, 2003

• 2) 日本循環器学会ほか : 循環器疾患における抗凝固・抗血小板療法に関するガイドライン. Jpn Circ J 68 : 1153-1219, 2004

• 3) Cerebral Embolism Task Force : Cardiogenic brain embolism. Arch Neurol 43 : 71-84, 1986
  pubmed

• 4) Adams HP Jr, Bendixen BH, Kappelle LJ et al : Classification of subtype of acute ischemic stroke : definition for use in a multicenter clinical trial. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 : 35-41, 1993

• 5) Lamas GA, Lee KL, Sweeney MO et al : Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346 : 1854-1862, 2002

• 6) Connolly SJ, Kerr CR, Gent M et al : Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 342 : 1385-1391, 2000

• 7) Hart RG, Benavente O, McBride R et al : Antithrombotic therapy to prevent stroke in patients with atrial fibrillation : a meta analysis. Ann Intern Med 131 : 492-501, 1999
  pubmed

• 8) 橋本洋一郎ほか : 脳梗塞の診断と治療-ブレインアタック時代の新たな展開-, 診療新社, 大阪, 1999

• 9) 小林祥泰監, 田中耕太郎, 中川原譲二, 橋本洋一郎編 : 脳卒中ナビゲーター, メディカルレビュー社, 東京, 2002

• 10) Bogousslavsky J, Regli F, UskeA et al : Early spontaneous hematoma in cerebral infarct : Is primary cerebral hemorrhage overdiagnosed? Neurology 41 : 837-840, 1991
  pubmed

• 11) Okada Y, Yamaguchi T, Minematsu K et al : Hemorrhagic transformation in cerebral embolism. Stroke 20 : 598-603, 1989
  pubmed

P.106 掲載の参考文献

• 1) Ueda K, Kiyohara Y, Hasuo Y et al : Transient cerebral ischemic attacks in a Japanese community, Hisayama, Japan. Stroke 18 : 844-848, 1987

• 2) Johnston SC, Gress DR, Browner WS et al : Short-term prognosis after emergency department diagnosis of TIA. JAMA 284 : 2901-2906, 2000
  pubmed

• 3) Brown RD Jr, Petty GW, O'Fallon WM et al : Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke 29 : 2109-2113, 1998
  pubmed

• 4) Benavente O, Eliasziw M, Streifler JY et al : Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med 345 : 1084-1090, 2001
  pubmed

• 5) Fisher CM : Occlusion of the internal carotid artery. Arch Neurol 65 : 346-377, 1951

• 6) Fisher CM : Observations of the fundus oculi in transient monocular blindness. Neurology 9 : 333-347, 1959
  pubmed

• 7) 吉永まゆみ, 山口武典 : 一過性脳虚血発作の発症機序と予後-連続183例の検討-. 循環器病研究の進歩 9 : 45-52, 1988

• 8) Sempere AP, Duarte J, Cabezas C et al : Etiopathogenesis of transient ischemic attacks and minor ischemic strokes : a communitybased study in Segovia, Spain. Stroke 29 : 40-45, 1998
  pubmed

• 9) Donnan GA, O'Malley HM, Quang L et al : The capsular warning syndrome : pathogenesis and clinical features. Neurology 43 : 957-962, 1993
  pubmed

• 10) Burger SK, Saul RF, Selhorst JB et al : Transient monocular blindness caused by vasospasm. N Engl J Med 325 : 870-873, 1991
  pubmed

• 11) Hankey GJ, Warlow CP : Lacunar transient ischaemic attacks : a clinically useful concept? Lancet 337 : 335-338, 1991
  pubmed

• 12) Evans GW, Howard G, Murros KE et al : Cerebral infarction verified bycranial computed tomography and prognosis for survival following transient ischemic attack. Stroke 22 : 431-436, 1991
  pubmed

• 13) Ay H, Koroshetz WJ, Benner T et al : Transient ischemic attack with infarction : a unique syndrome? Ann Neurol 57 : 679-86, 2005
  pubmed

• 14) Albers GW, Caplan LR, Easton JD et al : Transient ischemic attack-proposal for a new definition. N Engl J Med 347 : 1713-1716, 2002
  pubmed

P.112 掲載の参考文献

• 1) Ueda K, Hasuo Y, Kiyohara Y et al : Intracerebral hemorrhage in a Japanese community, Hisayama : incidence, changing pattern during long-term follow-up, and related factors. Stroke 19 : 48-52, 1988

• 2) Wakai S, Nagai M : Histological verification of microaneurysms as a cause of cerebral haemorrhage in surgical specimens. J Neurol Neurosurg Psychiatry 52 : 595-599, 1989
  pubmed

• 3) Masawa N : Morphometry of structural preservation of tunica media in aged and hypertensive human intracerebral arteries. Stroke 25 : 122-127, 1994
  pubmed

• 4) Neaton JD, Blackburn H, Jacobs D et al : Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 152 : 1490-1500, 1992
  pubmed

• 5) Takebayashi S, Kaneko M : Electron microscopic studies of ruptured arteries in hypertensive intracerebral hemorrhage. Stroke 14 : 28-36, 1983
  pubmed

• 6) Dubas F : Small vessel pathology and cerebral hemorrhage. J Neuroradiol 30 : 298-302, 2003
  pubmed

• 7) Becker KJ, Baxter AB, Bybee HM et al : Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 30 : 2025-2032, 1999
  pubmed

• 8) Fujii Y, Tanaka R, Takeuchi S et al : Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80 : 51-57, 1994
  pubmed

• 9) Carlberg B, Asplund K, Hagg E : Factors influencing admission blood pressu relevels in patients with acute stroke. Stroke 22 : 527-530, 1991

• 10) Fogelholm R, Avikainen S, Murros K : Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28 : 1396-1400, 1997
  pubmed

• 11) Mayer SA, Lingnelli A, Fink ME et al : Perilesional blood flow and edema formation in acute intracerebral hemorrhage : a SPECT study. Stroke 29 : 1791-1798, 1998
  pubmed

• 12) Zazulia AR, Diringer MN, Videen TO et al : Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 21 : 804-810, 2001
  pubmed

• 13) Wahl M, Unterberg A, Baethmann A et al : Mediators of bloodbrain barrier dysfunction and formation of vasogenic brain edema. J Cereb Blood Flow Metab 8 : 621-634, 1988
  pubmed

• 14) Lee KR, Kawai N, Kim S et al : Mechanisms of edema formation after intracerebral hemorrhage : effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 86 : 272-278, 1997

• 15) 佐々木雄彦, 松崎隆幸, 中川原譲二ほか : 高血圧性基底核部出血に対するグリセロールの脳血流改善作用. 脳神経 35 : 505, 1983

• 16) Karibe H, Shimizu H, Tominaga T et al : Diffusion-weighted magnetic resonance imaging in the early evaluation of corticospinal tract injury to predict functional motor outcome in patients with deep intracerebral hemorrhage. J Neurosurg 92 : 58-63, 2000
  pubmed

P.119 掲載の参考文献

• 1) van Gijn J, Rinkel GJ : Subarachnoid haemorrhage : diagnosis, causes and management. Brain 124 : 249-278, 2001
  pubmed

• 2) Onda H, Kasuya H, Yoneyama T et al : Genomewide-linkage and haplotype-association studies mapintracranial aneurysm to chromosome 7q11. Am J Hum Genet 69 : 804-819, 2001

• 3) Olson JM, Vongpunsawad S, Kuivaniemi H et al : Search for intracranial aneurysm susceptibility gene (s) using Finnish families. BMC Med Genet 3 : 7-14, 2002

• 4) Yamada S, Utsunomiya M, Inoue K et al : Genome-wide scan for Japanese familial intracranial aneurysms : linkage to several chromosomal regions. Circulation 110 : 3727-3733, 2004
  pubmed

• 5) Hashimoto N, Handa H, Hazama F : Experimentally induced cerebral aneurysms in rats. Surg Neurol 10 : 3-8, 1978
  pubmed

• 6) Sadamasa N, Nozaki K, Hashimoto N : Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 34 : 2980-2984, 2003
  pubmed

• 7) Nornes H, Magnaes B : Intracranial pressure in patients with ruptured saccular aneurysm. J Neurosurg 36 : 537-547, 1972
  pubmed

• 8) Wiebers DO, Whisnant JP, Huston J 3rd et al : Unruptured intracranial aneurysms : natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362 : 103-110, 2003
  pubmed

P.129 掲載の参考文献

• 1) Flemming KD, Brown RD Jr : Natural history of intracranial vascular malformations. Winn HR, YOUMANS Neurological Surgery 5th edition, SAUNDERS, New York, 2004, p.2159-2183

• 2) Bulsara KR, Alexander MJ, Villavicencio AT et al : De novo cerebral arteriovenous malformation : case report. Neurosurgery 50 : 1137-1140, 2002
  pubmed

• 3) Sure U, Butz N, Schlegel J et al : Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94 : 972-977, 2001
  pubmed

• 4) 中里洋一 : 脳動静脈奇形の病理所見. 脳神経外科Advenced Practice (6) (斉藤勇編), メジカルビュー社, 東京, 2002, p.20-25

• 5) Ogilvy CS, Stieg PE, Awad I et al : AHA Scientific Statement : Recommendations for the management of intracranial arteriovenous malformations : a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 32 : 1458-1471, 2001
  pubmed

• 6) Al-Shahi R, Warlow C : A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain 124 : 1900-1926, 2001
  pubmed

• 7) Monteiro JM, Rosas MJ, Correia AP et al : Migraine and intracranial vascular malformations. Headache 33 : 563-565, 1993
  pubmed

• 8) Mast H, Mohr JP, Osipov A et al : ‘Steal'is an unestablished mechanism for the clinical presentation of cerebral arteriovenous malformations. Stroke 26 : 1215-1220, 1995

• 9) Spetzler RF, Martin NA : A proposed grading system for arteriovenous malformations. J Neurosurg 65 : 476-483, 1986
  pubmed

• 10) Kurita H, Kawamoto S, Suzuki I et al : Control of epilepsy associated with cerebral arteriovenous malformations after radiosurgery. J Neurol Neurosurg Psychiatry 65 : 648-655, 1998
  pubmed

P.139 掲載の参考文献

• 1) Kuroda S, Nanba R, Ishikawa T et al : Clinical manifestations of infantile moyamoya disease. No Shinkei Geka 31 : 1073-1078, 2003
  pubmed

• 2) Hong YH, Ahn TB, Oh CW et al : Hemichorea as an initial manifestation of moyamoya disease : reversible striatal hypoperfusion demonstrated on single photon emission computed tomography. Mov Disord 17 : 1380-1383, 2002
  pubmed

• 3) Im SH, Oh CW, Kwon OK et al : Involuntary movement induced by cerebral ischemia : pathogenesis and surgical outcome. J Neurosurg 100 : 877-882, 2004
  pubmed

• 4) Kuroda S, Houkin K, Kamiyama H et al : Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease : report of three cases. Neurosurgery 49 : 463-467, 2001
  pubmed

• 5) Miyamoto S;Japan Adult Moyamoya Trial Group : Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset-the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 44 : 218-219, 2004

• 6) Kuroda S, Ishikawa T, Houkin K et al : Clinical significance of posterior cerebral artery stenosis/occlusion in moyamoya disease. No Shinkei Geka 30 : 1295-1300, 2002
  pubmed

• 7) Kuroda S, Houkin K, Nunomura M et al : Frontal lobe infarction due to hemodynamic change after surgical revascularization in moyamoya disease-two case reports. Neurol Med Chir (Tokyo) 40 : 315-320, 2000
  pubmed

P.155 掲載の参考文献

• 1) 篠原幸人 : 脳静脈, 静脈洞血栓症. 脳血管の臨床 (後藤文男編), 中外医学社, 東京, 1983, p.549-560

• 2) Einhaupl KM, Masuhr F : Cerebral venous and sinua thrombosis-an update. Eur J Neurol 1 : 109-126, 1994

• 3) 荒木信夫 : 特殊な脳梗塞の診断と治療B. 脳静脈洞血栓症. 神経内科 58 : 367-378, 2003

• 4) Chow K, Gobin YP, Saver J et al : Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke 31 : 1420-1425, 2000
  pubmed

• 5) Ferro JM, Correia M, Pontes C, et al : Cerebral vein and dural sinus thrombosis in Portugal : 1980-1998. Cerebrovasc Dis 11 : 177-182, 2001
  pubmed

• 6) 篠原幸人, 吉本高志, 福内靖男ほか : 脳静脈閉塞症における出血. 脳卒中治療ガイドライン2004 (脳卒中合同ガイドライン委員会編), 協和企画, 2004, 東京, p.130-131

• 7) 高木誠 : 動脈解離による脳卒中. 脳と循環 10 : 21-25, 2005

• 8) 高木誠 : 脳動脈解離の診断と治療の手引き. 若年脳卒中治療診察の手引き. 循環器病研究委託費12指-2若年世代の脳卒中の診断, 治療, 予防戦略に関する全国多施設共同研究 (主任研究者峰松一夫). 大阪, 国立循環器病センター, 2003, p.85-90

• 9) Touze E, Gauvrit JY, Moulin T et al : Risk of stroke and recurrent dissection after a cervical artery dissection : a multicenter study. Neurology 61 : 1347-1351, 2003
  pubmed

• 10) Pelkonen O, Tikkakoski T, Pyhtinen J et al : Cerebral CT and MRI findings in cervicocephalic artery dissection. Acta Radiol 45 : 259-265, 2004
  pubmed

• 11) Kumazawa R, Takizawa S, Okuma H et al : Crossed pontine infarction caused by vertebro-basilar artery dissection. Intern Med 44 : 520-521, 2005
  pubmed

• 12) Lyrer P, Engelter S : Antithrombotic drugs for carotid artery dissection. Cochrane, Oatabase Syst Rev 3 : CD000255, 2003
  pubmed

• 13) Schievink WI : The treatment of spontaneous carotid and vertebral artery dissections. Curr Opin Cardiol 15 : 316-321, 2000
  pubmed

Chapter3 脳卒中の診断

P.161 掲載の参考文献

• 1) 高木誠 : 初診時の問診・診察の流れ. Medicina 34 : 2301-2303, 1997

• 2) 高木誠 : 昏睡患者の診かた. Medicina 23 : 1840-1844, 1986

• 3) 高木誠 : 本邦における椎骨脳底動脈解離の特徴とその診断・治療の現状と問題点. 脳神経 54 : 203-211, 2002

• 4) 高木誠 : 脳梗塞の臨床症候-テント下. Medicina 32 : 2185-2187, 1995

• 5) 高木誠 : 糖尿病. Clin Neurosci 8 : 196-197, 1990

P.167 掲載の参考文献

• 1) Tomura N, Uemura K, Inugami A et al : Early CT finding in cerebral infarction : obscuration of the lentiform nucleus. Radiology 168 : 463-467, 1988
  pubmed

• 2) Becker H, Desch H, Hacker H et al : CT fogging effect with ischemic cerebral infarcts. Neuroradiology 18 : 185-192, 1979
  pubmed

• 3) Burdette JH, Ricci PE, Petitti N et al : Cerebral infarction : time course of signal intensity changes on diffusion-weighted MR images. AJR Am J Roentgenol 171 : 791-795, 1998
  pubmed

• 4) Gomori JM, Grossman RI, Goldberg HI et al : Intracranial hematomas : imaging by high-field MR. Radiology 157 : 87-93, 1985

P.171 掲載の参考文献

• 1) Shimosegawa E, Hatazawa J, Inugami A et al : Cerebral infarction with in six hours of onset : Prediction of completed infarction with technetium-99m-HMPAO SPECT. J Nucl Med 35 : 1097-1103, 1994
  pubmed

• 2) Ueda T, Sakaki S, Yuh WT et al : Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab 19 : 99-108, 1999

• 3) Kuroda S, Houkin K, Kamiyama H et al : Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion : can acetazolamide test predict it? Stroke 32 : 2110-2116, 2001

• 4) Ogasawara K, Ogawa A, Konno H et al : Combination of early and delayed SPET imaging using technetium-99m ethyl cysteinate dimer immediately after local intra-arterial thrombolysis. Eur J Nucl Med 28 : 498-505, 2001
  pubmed

• 5) Yamauchi H, Fukuyama H, Nagahama Y et al : Evidence of misery perfusion and risk for recurrent stroke in majorcerebral arterial occlusive diseases from PET. J Neurol Neurosurg Psychiatry 61 : 18-25, 1996

• 6) Hatazawa J, Shimosegawa E, Satoh T et al : Subcortical hypoperfusion associated with asymptomatic white matter lesions on magnetic resonance imaging. Stroke 28 : 1944-1947, 1997
  pubmed

P.179 掲載の参考文献

• 1) Gronholdt ML, Nordestgaard BG, Schroeder TV et al : Ultrasonic echolucent carotid plaques predict future strokes. Circulation 104 : 68-73, 2001
  pubmed

• 2) AbuRahma AF, Wulu JT Jr, Crotty B : Carotid plaque ultrasonic heterogeneity and severity of stenosis. Stroke 33 : 1772-1775, 2002
  pubmed

• 3) Aaslid R, Markwalder TM, Nornes H : Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 57 : 769-774, 1982
  pubmed

• 4) Spencer MP, Thomas GI, Nicholls SC et al : Detection of middle cerebral artery emboli during carotid endarterectomy using transcranial Doppler ultrasonography. Stroke 21 : 415-423, 1990
  pubmed

P.185 掲載の参考文献

• 1) 藤井清孝, 岡田靖編 : ブレインアタック-超急性期の脳卒中診療, 中山書店, 東京, 1999, p.122-126

• 2) 水野美邦編 : 神経内科ハンドブック-鑑別診断と治療, 医学書院, 東京, 2003, p.7-28

• 3) 田川皓一, 佐藤睦子 : 第III章主要症候と責任病巣, 第V章神経心理学の評価, 神経心理学を理解するための10章, 新興医学出版社, 東京, 2004

• 4) Hoffmann M : Higher cortical function deficits after stroke : an analysis of 1,000 patients from a dedicated cognitive stroke registry. Neurorehabil Neural Repair 15 : 113-127, 2001
  pubmed

• 5) 高尾昌樹, 岡安裕之 : 脳梗塞. c. 神経症候 (血管支配領域別). 神経内科 58 (Suppl. 3) : 200-205, 2003

Chapter4 脳卒中治療薬の薬理作用

P.192 掲載の参考文献

• 1) 内山真一郎 : 抗血小板薬. 脳血栓症の治療 (藤島正敏, 山口武典編), メディカルトリビューン, 東京, 1993, p.91-106

• 2) Antithrombotic Trialists'Collaboration : Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71-86, 2002
  pubmed

• 3) Hankey GJ, Eikelboom JW : Aspirin resistance. BMJ 328 : 477-479, 2004
  pubmed

• 4) Hollopeter G, Jantzen HM, Vincent D et al : Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409 : 202-207, 2001
  pubmed

• 5) Uchiyama S, Yamazaki M, Maruyama S et al : Shear-induced platelet aggregation in cerebral ischemia. Stroke 25 : 1547-1551, 1994
  pubmed

• 6) Yamazaki M, Uchiyama S, Iwata M et al : Measurement of platelet fibrinogen binding and p-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 104 : 197-205, 2001
  pubmed

• 7) 池田康夫, 内山真一郎, 山口武典ほか : 硫酸クロピドグレルの血小板凝集抑制作用-用量比較臨床薬理試験-. 脳卒中 24 : 381-392, 2002

• 8) Nakamura T, Uchiyama S, Yamazaki M et al : Effects of dipyridamole and aspirin onshear-induced platelet aggregation in whole blood and platelet-rich plasma. Cerebrovasc Dis 14 : 234-238, 2002
  pubmed

• 9) Sorkin EM, Markham A : Cilostazol. Drugs, Aging 14 : 63-71, 1999
  pubmed

• 10) Yamazaki M, Uchiyama S, Xiong Y et al : Effect of remnant-like particle on shear-induced platelet activation and its inhibition by antiplatelet agents. Thromb Res 115 : 211-218, 2005
  pubmed

• 11) Hara H, Osakabe M, Kitajima A et al : MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost 65 : 415-420, 1991
  pubmed

• 12) 内山真一郎, 山崎昌子. 新しい抗血小板療法-GP IIb/IIIa阻害薬-. 脳血管障害とその治療-神経・筋疾患の最新医療 (杉田秀夫, 福内靖男, 柴崎浩監) 先端医療シリーズ14神経・筋疾患, 先端医療技術研究所, 東京, 2001, p.78-82

P.202 掲載の参考文献

• 1) 櫻川信男, 青崎正彦, 上塚芳郎ほか : 抗凝固薬の適正な使い方, 医歯薬出版, 東京, 2000

• 2) 長尾毅彦 : 抗凝固療法. 脳血管障害の治療脳血管障害シリーズIII (矢崎義雄監), 現代医療社, 東京, 1999, p.83-101

• 3) 内山真一郎 : 抗血栓療法はどこまで有効か. 脳梗塞とTIA (transiend ischemic attack). 日常診療と血液 7 : 905-914, 1997

• 4) 非弁膜性心房細動 (Nonvalvular Atrial Fibrillation) による心原性脳塞栓症の二次予防に関する共同研究班 : 抗凝血薬療法のモニタリングとしてのInternational Normalized Ratio. -International Sensitivity Indexの必要性-. 脳卒中 18 : 124-129, 1996

• 5) Yasaka M, Minematsu K, Naritomi H et al : Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 89 : 278-283, 2003
  pubmed

• 6) Yasaka M, Sakata T, Naritomi H et al : Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. Thromb Res 115 : 455-459, 2005
  pubmed

• 7) Olsson SB;Executive Steering Committee on behalf of the SPORTIF III Investigators : Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III) : randomised controlled trial., Lancet 362 : 1691-1698, 2003

• 8) Albers GW : Stroke prevention in atrial fibrillation : pooled analysis of SPORTIF III and V trials. Am J Manag Care 10 : S462-S473, 2004
  pubmed

• 9) Buller HR, Davidson BL, Decousus H et al;Matisse Invetigators : Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349 : 1695-1702, 2003

• 10) Warkentin TE, Kelton JG : Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 135 : 502-506, 2001
  pubmed

• 11) Pohl C, Kredteck A, Bastians B et al : Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin. Neurology 64 : 1285-1287, 2005
  pubmed

P.211 掲載の参考文献

• 1) Adams HP Jr, Brott TG, Furlan AJ et al : Guidelines for thrombolytic therapy for acute stroke : a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke 27 : 1711-1718, 1996

• 2) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 : 1581-1587, 1995

• 3) Wardlaw J, del Zoppo G, Yamaguchi T et al : Thrombolysis for Acute Ischemic Stroke. Stroke 35 : 2914-2915, 2004

• 4) Yamaguchi T, Mori E, Minematsu K et al : Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset;Japan Alteplase Clinical Trial (J-ACT). ［In submission］

• 5) Matsuo O : New thrombolytic agents : basic development. Thrombolytic thrapy in acute ischemic stroke III, Springer-Verlag, Tokyo, 1995, p.182-187

• 6) Molina CA, Saver JL : Extending reperfusion therapy for acute ischemic stroke : emergin gpharmacological, mechanical, and imaging strategies. Stroke 36 : 2311-2320, 2005

• 7) Hacke W, Albers G, Al-Rawi Y et al : The Desmoteplase in Acute Ischemic Stroke Trial (DIAS) : a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 : 66-73, 2005

• 8) Furlan A, Higashida R, Wechsler L et al : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 : 2003-2011, 1999
  pubmed

• 9) Hacke W, Donnan G, Fieschi C et al : Association of outcome with early stroke treatment : pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 : 768-774, 2004
  pubmed

• 10) Haley EC Jr, Lyden PD, Johnston KC et al : A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 36 : 607-612, 2005
  pubmed

P.219 掲載の参考文献

• 1) 浅野孝雄編著 : 脳虚血の病態学, 中外医学社, 東京, 2004

• 2) Botterell EH et al : Hypothermia, and interruption of carotid, or carotid and vertebral circulation, in the surgical management of intracranial aneurysms. J Neurosurg 13 : 1-42, 1956
  pubmed

• 3) Arnfred I, Secher O : Anoxia and barbiturates : tolerance to anoxia in mice influenced by barbiturates. Arch Int Pharmacodyn 139 : 67-74, 1962

• 4) Michenfelder JD, Milde JH, Sundt TM Jr : Cerebral protection by barbiturate anesthesia. Use after middle cerebral artery occlusion in Java monkeys. Arch Neurol 33 : 345-350, 1976
  pubmed

• 5) Abe K, Yuki S, Kogure K : Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 : 480-485, 1988

• 6) Watanabe T, Morita I, Nishi H et al : Preventive effect of MCI-186 On 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids 33 : 81-87, 1988
  pubmed

• 7) Zhang WR et al : Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol Res 26 : 342-348, 2004

P.227 掲載の参考文献

• 1) 日本高血圧学会高血圧治療ガイドライン作成委員会 : 降圧薬治療, 臓器障害を合併する高血圧. 高血圧治療ガイドライン2004, ライフサイエンス出版, 東京, 2004, p.28-46

Chapter5 脳卒中急性期治療の実際

P.236 掲載の参考文献

• 1) 渡邊庸子, 渡辺俊明, 安東賢太郎ほか : ラジカル消去薬3-methyl-1-pehbyl-2-pyrazolin-5-one (MCI-186) と脳卒中急性期治療薬の相互作用の検討. 薬理と治療 25 : S1709-S1717, 1997

• 2) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 : 1581-1587, 1995

• 3) Hacke W, Kaste M, Fieschi C et al : Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet 352 : 1245-1251, 1998

• 4) 峰松一夫, 山口武典, 端和夫ほか : 発症3時間以内の虚血性脳血管障害に対するGMK-527 (アルテプラーゼ) 静注療法臨床試験の結果. 脳卒中 26 : 603-606, 2004
  Medical*Online

• 5) Yamaguchi T, Mori E, Minematsu K et al for the Japan Alteprase Clinical Trial (J-ACT) Group : Alteprase at 0.6mg/kg for acute ischemic stroke within 3 hours of onset : Japan Alteprase Cinical Trial. ［in submission］

P.246 掲載の参考文献

• 1) Naito J, Komatsu H, Ujiie A et al : Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets. Eur J Pharmacol 91 : 41-48, 1983
  pubmed

• 2) 大友英一, 沓沢尚之, 小暮久也ほか : 脳血栓症急性期におけるOKY-046の臨床的有用性-プラセボを対照とした多施設二重盲検試験-. 臨床医薬 7 : 353-388, 1991
  Medical*Online

• 3) The Intercollediate Working Party of Stroke. National clinical guideline for stroke. Clinical Effectiveness & Evaluation Unit. London : Royal College of Physician;2000

• 4) Antithrombotic Trialists'Collaboration : Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71-86, 2003

• 5) International Stroke Trial Collaborative Group : The International Stroke Trial (IST) : a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 : 1569-1581, 1997
  pubmed

• 6) CAST (Chinese Acute Stroke Trial) Collaborative Group : CAST : randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349 : 1641-1649, 1997

P.253 掲載の参考文献

• 1) Sandercock PAG, Collins R, Counsell C et al : The International Stroke Trial (IST) : A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 : 1569-1581, 1997
  pubmed

• 2) Kay R, Wong KS, Yu YL et al : Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 333 : 1588-1593, 1995
  pubmed

• 3) The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators : Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke : a randomized controlled trial. JAMA 279 : 1265-1272, 1998
  pubmed

• 4) 田崎義昭, 小林祥泰, 東儀英夫ほか : 脳血栓症急性期に対する抗トロンビン薬MD-805の臨床的有用性-プラセボを対照とした多施設二重盲検群間比較試験. 医学のあゆみ 161 : 887-907, 1992

• 5) Kobayashi S, Tazaki Y : Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost 23 : 531-534, 1997
  pubmed

• 6) LaMonte MP, Nash ML, Wang DZ et al : Argatroban anticoagulation in patients with acuteischemic stroke (ARGIS-1) : a randomized, placebo-controlled safety study. Stroke 35 : 1677-1682, 2004

• 7) Gubitz G, Counsell C, Sandercock P et al : Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev 2000 : CD000024

• 8) Fisher CM : Lacunar strokes and infarcts : a review. Neurology 32 : 871-876, 1982
  pubmed

• 9) Lewis BE, Wallis DE, Berkowitz SD et al : Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103 : 1838-1843, 2001
  pubmed

P.261 掲載の参考文献

• 1) Yamaguchi T, Hayakawa T, Kikuchi H;Japanese Thrombolysis Study Group : Intravenous tissue plasminogen activator ameliorates the outcome of hyperacut eembolic stroke. Cerebrovasc Dis 3 : 269-272, 1993

• 2) The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 : 1581-1587, 1995

• 3) Hacke W, Kaste M, Fieschi C et al : Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274 : 1017-1025, 1995
  pubmed

• 4) Hacke W, Kaste M, Fieschi C et al : Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 352 : 1245-1251, 1998
  pubmed

• 5) Clark WM, Albers GW, for the ATLANTIS Stroke Study Investigators : The ATLANTIS rt-PA (Alteplase) acute stroke trial : Final results. Stroke 30 : 234, 1999

• 6) Multicentre Acute Stroke Trial-Italy (MAST-I) Group : Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet 346 : 1509-1514, 1995

• 7) Hommel M, Boissel JP, Cornu C et al : Multicentre Acute Stroke Trial Europe : Thrombolytic stroke. N Engl J Med 335 : 145-150, 1996

• 8) Donnan GA, Davis SM, Dhambers BR et al : Streptokinase for acute ischemic stroke with relation to time of administration. JAMA 276 : 961-966, 1996

• 9) Furlan A, Higashida R, Wechsler L et al : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 21 : 2003-2011, 1999
  pubmed

• 10) 江面正幸, 松本康史, 高橋明 : 急性期局所線溶療法の現状. 脳外誌 13 : 111-115, 2004

• 11) 江面正幸, 川岸潤, 西村真実ほか : 中大脳動脈塞栓症に対する局所線溶療法. 脳卒中 22 : 520-523, 2000
  Medical*Online

• 12) Ezura M, Takahashi A, Shimizu H et al : Diffusion-weighted magnetic resonance imaging as an indicator for fibrinolytic therapy in patients with acute ischemic events. Neuroradiol 42 : 379-383, 2000

P.268 掲載の参考文献

• 1) Broderick JP, Adams HP Jr, BarsanW et al : Guidelines for the management of spontaneous intracerebral hemorrhage : A statement for healthcare professional from a special writing group of the Stroke Council, American Heart Association. Stroke 30 : 905-915, 1999

• 2) Abe K, Yuki S, Kogure K : Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 : 480-485, 1988

P.274 掲載の参考文献

• 1) Abe K, Yuki S, Kogure K : Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 : 480-485, 1988

• 2) The Edaravone Acute Brain Infarction Study Group : Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction : randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15 : 222-229, 2003

• 3) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004

• 4) 小林祥泰編 : 脳卒中データバンク2005, 中山書店, 東京, 2005, p.80-81

• 5) Toyoda K, Fujii K, Kamouchi M et al : Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J Neurol Sci 221 : 11-17, 2004
  pubmed

• 6) 高畠靖志, 宇野英一, 若松弘一ほか : 脳梗塞急性期治療におけるエダラボン・オザグレル併用療法の有用性. 脳と神経 55 : 589-593, 2003

• 7) Ogasawara K, Inoue T, Kobayashi M et al : Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery 55 : 1060-1067, 2004
  pubmed

P.280 掲載の参考文献

• 1) Adams HP Jr, Brott TG, Crowell RM et al : Guidelines for the management of patients with acute ischemic storke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 25 : 1901-1914, 1994

• 2) Dirnagl U, Lindauer U : Microcirculatory disturbances in cerebral ischemia. In : Cerebrobascular disease;pathophysiology, diagnosis, and management (Ginsberg MD and Bogousslavsky J eds. ), Blackwell Science, Berlin;Viena, 1998, p.343-357

• 3) Kitazono T, Faraci FM, Taguchi H et al : Role of potassium channels in cerebral blood vessels. Stroke 26 : 1713-1723, 1995
  pubmed

• 4) Santa N, Kitazono T, Ago T et al : ATP-sensitive potassium channels mediate dilatation of basilar artery in response to intracellular acidification in vivo. Stroke 34 : 1276-1280, 2003
  pubmed

• 5) Iadecola C : Cerebral circulatory dysregulation in ischemia. In : Cerebrovascular disease;pathophysiology, diagnosis, and management (Ginsberg MD and Bogousslavsky J eds. ), Blackwell Science, Berlin;Viena, 1998, p.319-332

• 6) Broderick JP, Adams HP Jr, Barsan W et al : Guidelines for the manegement of spontaneous intracerebral hemorrhage. Stroke 30 : 905-915, 1999

• 7) Adams HP Jr, Adams RJ, Brott TG et al : Guidelines for the early management of patients with acute ischemic stroke. Stroke 34 : 1056-1083, 2003

• 8) 日本高血圧学会高血圧治療ガイドライン作成委員会 : 高血圧治療ガイドライン2004年版, ライフサイエンス出版, 東京, 2004

• 9) Adams HP Jr, Brott TG, Furlan AJ et al : Guidelines for thrombolytic therapy for acute stroke : a supplement to the guidelines for the manegement of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 94 : 1167-1174, 1996

• 10) 脳卒中合同ガイドライン委員会 : 脳卒中ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004

• 11) Schrader J, Luders S, Kuluschewski A et al : The ACCESS study;evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 34 : 1699-1703, 2003
  pubmed

P.287 掲載の参考文献

• 1) Broderick JP, Adams HP Jr, Barsan W et al : Guidelines for the management of spontaneous intracerebral hemorrhage : A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30 : 905-915, 1999
  pubmed

• 2) 脳卒中合同ガイドライン委員会 : 脳出血手術治療法の選択. 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004, p.114-118

• 3) 金谷春之, 斎木巌 : 高血圧性脳出血の手術. 解剖を中心とした脳神経手術手技-第1巻血管性病変 (松本健五, 長島正, 池崎清信編), 医学書院, 東京, 1999, p.309-312

• 4) 永田和哉, 河本俊介編 : 脳出血の手術1) 皮質下出血. 脳神経外科手術の基本手技, 中外医学社, 東京, 2003, p.118-122

• 5) Montes JM, Wong JH, Fayad PB et al : Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma : protocol and preliminary experience. Stroke 31 : 834-840, 2000
  pubmed

• 6) Schaller C, Rohde V, Meyer B et al : Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery 36 : 328-333, 1995
  pubmed

• 7) Teernstra OP, Evers SM, Lodder J et al : Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator : a multicenter randomized controlled trial (SICHPA). Stroke 34 : 968-974, 2003
  pubmed

• 8) 金谷春之 : 高血圧性脳出血の治療と現況-全国調査の成績より. 脳卒中 12 : 509-524, 1990

• 9) Auer LM, Deinsberger W, Niederkorn K et al : Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma : a randomized study. J Neurosurg 70 : 530-535, 1989
  pubmed

• 10) Mendelow AD, Gregson BA, Fernandes HM et al : Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH) : a randomised trial. Lancet 365 : 387-397, 2005

P.293 掲載の参考文献

• 1) Molyneux A, Kerr R, Stratton I et al;International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group : International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms : a randomised trial. Lancet 360 : 1267-1274, 2002

• 2) Ogilvy CS : Neurosurgical clipping versus endovascular coiling of patients with ruptured intracranial aneurysms. Stroke 34 : 2540-2542, 2003
  pubmed

• 3) Kassell NF, Torner JC, Jane JA et al : The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2 : Surgical results. J Neurosurg 73 : 37-47, 1990

• 4) 斉藤延人 : 脳動脈瘤手術に併用するバイパス術. 脳神経外科速報 5 : 134-138, 2005

P.300 掲載の参考文献

• 1) Kistler JP, Crowell RM, Davis KR et al : The relation of cerebral vasospasm to the extent and Iocation of subarachnoid blood visualized by CT scan : a prospective study. Neurology 33 : 424-436, 1983

• 2) Aaslid R, Huber P, Nornes H : Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 60 : 37-41, 1984
  pubmed

• 3) Findlay JM, Kassell NF, Weir BK et al : A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37. 168-176, 1995
  pubmed

• 4) Sasaki T, Kodama N, Kawakami M et al : Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage : a study of urokinase concentration and the fibrinolytic system. Stroke 31 : 1256-1262, 2000
  pubmed

• 5) Haley EC, Kassell NF, Torner JC et al : A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. J Neurosurg 78 : 537-547, 1993
  pubmed

• 6) Awad IA, Carter LP, Spetzler RF et al : Clinical vasospasm after subarachnoid hemorrhage : response to hypervolemic hemodilution and arterial hypertension. Stroke 18 : 365-372, 1987
  pubmed

• 7) Higashida RT, Halbach VV, Cahan LD et al : Transluminal angioplasty for treatment of intracranial arterialvasospasm. J Neurosurg 71 : 648-653, 1989
  pubmed

• 8) Kassell NF, Helm G, Simmons N et al : Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77 : 848-852, 1992
  pubmed

• 9) Tachibana E, Harada T, Shibuya M et al : Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien) 141 : 13-19, 1999
  pubmed

P.308 掲載の参考文献

• 1) Ogawa A, Yoshimoto T, Sakurai Y : Treatment of proximal vertebral artery stenosis. Vertebral to subclavian transposition. Acta Neurochir (Wien) 112 : 13-18, 1991
  pubmed

• 2) Nagashima C : ［Surgical treatment of vertebro-basilar insufficiency due to cervical spondylosis］. No To Shinkei 21 : 1100-1111, 1969
  pubmed

P.314 掲載の参考文献

• 1) Langhorne P, Williams BO, Gilchrist W et al : Do stroke units save lives? Lancet 342 : 395-398, 1993
  pubmed

• 2) Joergensen HS, Nakayama H, Raaschou HO et al : The effect of a stroke unit : reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 26 : 1178-1182, 1995

• 3) Stroke Unit Trialists'Collaboration : Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews. Issue 4, 2005

• 4) 山口武典 : 平成10年度厚生科学研究費補助金健康科学総合研究事業研究報告書, 1999, p.8

• 5) 長束一行, 峰松一夫, 成富博章 : Stroke care unitの現状と問題点当院のstroke care unitの現状と問題点. 脳卒中 22 : 74, 2000

• 6) 済生会熊本病院クリニカルパス推進プロジェクト : 脳梗塞クリニカルパス. 医療の質向上と業務改善に活かすクリニカルパス運用事例集. 日総研出版, 名古屋, 2001, p.144-151

• 7) 橋本洋一郎, 寺崎修司, 米原敏郎監;梶原和子, 重松節美編 : クリティカルパスについて. クリティカルパスの事例紹介. 脳梗塞看護マニュアル-急性期クリティカルパスを中心に-, メディカ出版, 大阪, 1999, p.95-142

P.325 掲載の参考文献

• 1) 鈴木明文, 矢田健一郎 : Stroke Care Unit (SCU) またはStroke Unit (SU). 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004, p.14-15

• 2) Maruishi M, Shima T, Okada Y et al : Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma. Neurol Med Chir (Tokyo) 41 : 300-304, 2001
  pubmed

P.330 掲載の参考文献

• 1) Stroke Unit Trialists'Collaboration : Collaborative systematic review of the randomised trial of organised inpatient (stroke unit) care after stroke. BMJ 314 : 1151-1159, 1997
  pubmed

• 2) Stroke Unit Trialists'Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev The Cochrane Library 2005 : 1;22-October-2004 Updated

• 3) 長谷川泰弘 : 急性期リハビリテーションとSroke Unit : 脳卒中の新たな治療戦略. 循環器病研究の進歩 43 : 28-33, 2003

P.336 掲載の参考文献

• 1) 荒木信夫 : 特殊な脳梗塞の診断と治療-脳静脈洞血栓症-. 神経内科 58 (Suppl. 3) : 367-378, 2003

• 2) Ferro JM, Canhao P, Stam J et al : Prognosis of cerebral vein and dural sinus thrombosis;results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35 : 664-670, 2004

• 3) 二宮充喜子, 古屋大典, 荒木信夫 : 妊娠・分娩と大脳静脈および脳静脈洞血栓症. 神経内科 61 : 19-25, 2004

• 4) Connor SEJ, Jarosz JM : Magnetic resonance imaging of cerebral venous sinus thrombosis. Clinical Radiology 57 : 449-461, 2002
  pubmed

• 5) Alper F, Kantarci M, Dane S et al : Importance of anatomical asymmetries of transverse sinuses;an MR venographic study. Cerebrovasc Dis 18 : 236-239, 2004

• 6) 武井和夫, 荒木信夫, 山元敏正ほか : 眼窩深部の疼痛で発症した横静脈洞血栓症の1例. 日本頭痛学会誌 29 : 124-126, 2002

• 7) Einhaupl KM, Villringer A, Meister W et al : Heparin treatment in sinus venous thrombosis. Lancet 338 : 597-600, 1991
  pubmed

• 8) 脳卒中合同ガイドライン委員会 : III脳出血. 5. 高血圧以外の原因による脳出血の治療. 5-5. 脳静脈閉塞症における出血. 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004, p.130-131

• 9) 山脇健盛 : 頭蓋内および頭蓋外の動脈解離. 神経内科 58 (Suppl. 3) : 476-487, 2003

• 10) Manabe H, Ohkuma H, Fujita S et al : Coil embolization of ruptured vertebral dissection in acute stage with interlocking detachable coils. Surg Neurol 47 : 476-480, 1997
  pubmed

P.343 掲載の参考文献

• 1) Davenport RJ, Dennis MS, Wellwood I et al : Complications after acute stroke. Stroke 27 : 415-420, 1996
  pubmed

• 2) Langhorne P, Stott DJ, Robertson L et al : Medical complications after stroke : a multicenter study. Stroke 31 : 1223-1229, 2000
  pubmed

• 3) Johnston KC, Li JY, Lyden PD et al : Medical and neurological complications of ischemic stroke : experience from the RANTTAS trial. Ranttas investigators. Stroke 29 : 447-453, 1998
  pubmed

• 4) Addington WR, Stephens RE, Gilliland KA : Assessing the laryngeal cough reflex and therisk of developing pneumonia after stroke : an interhospital comparison. Stroke 30 : 1203-1207, 1999

• 5) Kitamura T, Ito K : Acute gastric changes in patients with acute stroke. Part 1 : with reference to gastroendoscopic findings. Strohe 7 : 460-463, 1976

• 6) Misra UK, Kalita J, Pandey S et al : Predictors of gastrointestinal bleeding in acute intracerebral haemorrhage. J Neurol Sci 208 : 25-29, 2003
  pubmed

• 7) 川久保啓司, 藤島正敏 : 高齢者消化性潰瘍臨床研究の進歩基礎疾患・合併症における潰瘍治療脳血管障害. 日本臨床 60 : 1573-1579, 2002

• 8) Dennis MS, Lewis SC, Warlow C;FOOD Trial Collaboration : Routine oral nutritional supplementation for stroke patients in hospital (food) : a multicentre randomised controlled trial. Lancet 365 : 755-763, 2005
  pubmed

• 9) Dennis MS, Lewis SC, Warlow C : Effect of timing and method of enteral tube feeding for dysphagic stroke patients (food) : A multicentre randomised controlled trial. Lancet 365 : 764-772, 2005
  pubmed

• 10) Hajat C, Hajat S, Sharma P : Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients. Stroke 31 : 410-414, 2000
  pubmed

Chapter6 脳卒中慢性期治療の実際

P.348 掲載の参考文献

• 1) Antiplatelet Trialist' Collaboration : Collaborative overview of randomised trials of antiplatelet therapy. -I : Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 : 81-106, 1994
  pubmed

• 2) CAPRIE Steering Committee : A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 : 1329-1339, 1996

• 3) Gotoh F, Tohgi H, Hirai S et al : Cilostazol Stroke Prevention Study : a placebo-controlled double-blind trial for secondary prevention of cerebral ischemia. J Stroke Cerebrovasc Dis 9 : 147-157, 2000
  pubmed

• 4) Hart RG, Sherman DG, Easton JD et al : Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51 : 674-681, 1998
  pubmed

• 5) Gorelick PB, Sacco RL, Smith DB et al : Prevention of a first stroke : a review of guidelines and multidisciplinary consensus statement from the National Stroke Association. JAMA 281 : 1112-1120, 1999
  pubmed

• 6) Wolf PA, Clagett GP, Easton JD et al : Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare prefessionals from the Stroke Council of the American Heart Association. Stroke 30 : 1991-1994, 1999
  pubmed

P.354 掲載の参考文献

• 1) Albers GW, Sherman DG, Gress DR et al : Stroke prevention in nonvalvular atrial fibrillation : a review of prospective randomized trials. Ann Neurol 30 : 511-518, 1991
  pubmed

• 2) Wyse DG, Waldo AL, DiMarco JP et al;Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators : A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 : 1825-1833, 2002

• 3) 日本循環器学会 : 循環器疾患における抗凝固・抗血小板療法に関するガイドライン. Circ J 68 (Suppl) : 1221-1230, 2004

• 4) Eisen GM, Baron TH, Dominitz JA et al;American Society for Gastrointestinal Endoscopy : Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 55 : 775-779, 2002
  pubmed

P.361 掲載の参考文献

• 1) Kubo M, Kiyohara Y, Kato I et al : Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community : the Hisayama study. Stroke 34 : 2349-2354, 2003

• 2) 入江克実, 井林雪郎 : 降圧薬治療は脳卒中の再発予防にも有効か. EBMジャーナル 2 : 296-302, 2001
  Medical*Online

• 3) PROGRESS Collaborative Group : Randomised trial of aperindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet 358 : 1033-1041, 2001
  pubmed

• 4) Irie K, Yamaguchi T, Minematsu K et al : The J-curve phenomenon in stroke recurrence. Stroke 24 : 1844-1849, 1993

• 5) 入江克実 : 脳梗塞の再発にはJ-curve現象が存在するか?-肯定的な立場から-. 脳と循環 8 : 317-320, 2003
  Medical*Online

• 6) Rodgers A, MacMahon S, Gamble G et al : Blood pressure and risk of stroke in patients with cerebrovascular disease. The United Kingdom Transient Ischaemic Attack Collaborative Group. BMJ 313 : 147, 1996

• 7) 星野晴彦, 高木誠, 溝井令一ほか : 虚血性脳血管障害入院加療症例の長期脳血管障害再発に関する検討. 脳卒中 26 : 349-356, 2004
  Medical*Online

• 8) Boutitie F, Gueyffier F, Pocock S et al;INDANA Project Steering Committee. INdividual Data ANalysis of Antihypertensive intervention : J-shaped relationship between blood pressure and mortality in hypertensive patients : new insights from a meta-analysis of individual-patient data. Ann Intern Med 136 : 438-448, 2002

• 9) Rothwell PM, Howard SC, Spence JD;Carotid Endarterectomy Trialists'Collaboration : Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34 : 2583-2590, 2003
  pubmed

• 10) Schrader J, Luders S, Kulschewski A et al;MOSES Study Group : Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention : principal results of a prospective randomized controlled study (MOSES). Stroke 36 : 1218-1226, 2005

P.369 掲載の参考文献

• 1) 一ツ松勤, 井上亨, 卯田健ほか : 頸動脈病変を伴う全身性動脈硬化症 : Systemic vascular disease YY (SVDYY) 症候群の診断と治療方針. 脳外速報 12 : 187-190, 2002

• 2) 一ツ松勤, 井上亨 : EC-ICバイパス. 脳神経外科学大系9 閉塞性脳血管障害 (山浦晶ほか編), 中山書店, 東京, 2004, p.306-315

• 3) North American Symptomatic Carotid Endarterectomy Trial Collaborators : Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 : 445-453, 1991
  pubmed

• 4) European Carotid Surgery Trialists'Collaborative Group : Randomised trial of endarterectomy for recently symptomatic carotid stenosis : final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 : 1379-1387, 1998

• 5) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study : Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 : 1421-1428, 1995
  pubmed

• 6) Moore WS, Barnett HJ, Beebe HG et al : Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke 26 : 188-201, 1995

• 7) Biller J, Feinberg WM, Castaldo JE et al : Guidelines for carotid endarterectomy : a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 97 : 501-509, 1998
  pubmed

• 8) Barnett HJ, Meldrum HE, Eliasziw M;North American Symptomatic Carotid Endarterectomy Trial (NASCET) collaborators : The appropriate use of carotid endarterectomy. CMAJ 166 : 1169-1179, 2002
  pubmed

• 9) Rothwell PM, Eliasziw M, Gutnikov SA et al : Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363 : 915-924, 2004
  pubmed

• 10) Endo S, Kuwayama N, Hirashima Y;Japan Carotid Atherosclerosis Study : Japan Carotid Atherosclerosis Study : JCAS. Neurol Med Chir (Tokyo) 44 : 215-217, 2004
  pubmed

• 11) Kuroda S, Houkin K, Kamiyama H et al : Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion : can acetazolamide test predict it? Stroke 32 : 2110-2116, 2001

• 12) The EC/IC Bypass Study Group : Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemics troke : Results of an international randomized trial. N Engl J Med 313 : 1191-1200, 1985

• 13) JET Study Group : Japanese EC-IC Bypass Trial (JET study) : Study designと中間解析結果. 脳卒中の外科 30 : 97-100, 2002

P.375 掲載の参考文献

• 1) The EC/IC Bypass Study Group : Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. N Engl J Med 313 : 1191-1200, 1985

• 2) Powers WJ : Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 29 : 231-240, 1991
  pubmed

• 3) Yamauchi H, Fukuyama H, Nagahama Y et al : Significance of increased oxygen extraction fraction in five-year prognosig of major cerebral arterial occlusive diseases. J Nucl Med 40 : 1992-1998, 1999
  pubmed

• 4) Yamauchi H, Okazawa H, Kishibe Y et al : Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry 75 : 33-37, 2004
  pubmed

• 5) Kuroda S, Houkin K, Kamiyama H et al : Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion : can acetazolamide test predict it? Stroke 32 : 2110-2116, 2001

• 6) Ogasawara K, Ogawa A, Terasaki K et al : Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome : comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 22 : 1142-1148, 2002
  pubmed

• 7) JET Study Group : Japanese EC-IC Bypass Trial (JET Study) : 中間解析結果 (第二報). 脳卒中の外科 30 : 434-437, 2002

• 8) 小川彰 : 13指-3 脳主幹動脈閉塞による高次脳機能障害の病態と予防的治療に関する研究. 平成15年度循環器病研究委託費による研究報告2004, p.7-9.

• 9) 宮本享 : 出血発症成人もやもや病に関するJapan Adult Moyamoya (JAM) trial. 脳卒中 24 : 480-484, 2003

P.383 掲載の参考文献

• 1) North American Symptomatic Carotid Endarterectomy Trial Collaborators : Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Eng J Med 325 : 445-453, 1991

• 2) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study : Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 : 1421-1428, 1995
  pubmed

• 3) Kerber CW, Cromwell LD, Loehden OL : Catheter dilatation of proximal carotid stenosis during distal bifurcation endarterectomy. AJNR Am J Neuroradiol 1 : 348-349, 1980
  pubmed

• 4) Theron J, Courtheoux P, Alachkar F et al : New triple coaxial catheter system for carotid angioplasty with cerebral protection. AJNR Am J Neuroradiol 11 : 869-874, 1990
  pubmed

• 5) 坂井信幸 : 閉塞性脳血管障害・慢性期脳虚血-治療法-CAS. 脳神経外科学大系 (橋本信夫ほか編), 中山書店, 東京, 2004, p.284-305

• 6) Wholey MH, Al-Mubarek N, Wholey MH : Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 60 : 259-266, 2003
  pubmed

• 7) Terada T, Yamaga H, Tsumoto T et al : Use of an embolicprotection system during endovascular recanalization of a totally occluded cervical internal carotid artery at the chronic stage. Case report. J Neurosurg 102 : 558-564, 2005

• 8) Yadav JS, Wholey MH, Kuntz RE et al : Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 : 1493-1501, 2004
  pubmed

• 9) Hobson RW 2nd : CREST (Carotid Revascularization Endarterectomy versus Stent Trial) : background, design and current status. Semin Vasc Surg 13 : 139-143, 2000
  pubmed

• 10) 小林祥泰 : 脳梗塞急性期患者データベースの構築に関する研究. 健康科学総合研究事業平成13年度研究報告, 2002

• 11) Schumacher HC, Khaw AV, Meyers PM et al : Intracranial Revascularization Therapy : Angioplasty and Stenting. Curr Treat Options Cardiovasc Med 6 : 193-198, 2004
  pubmed

• 12) SSYLVIA Study Investigators : Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA) : study results. Stroke 35 : 1388-1392, 2004
  pubmed

P.388 掲載の参考文献

• 1) Jorgensen HS, Nakayama H, Raaschou HO et al : Recovery of walking function in stroke patients : the Copenhagen Stroke Study. Arch Phys Med Rehabili 76 : 27-32, 1995

• 2) Legg L, Langhorne P;Outpatient Service Trialists : Rehabilitation therapy services for stroke patients living at home : systematic review of randomised trials. Lancet 363 : 352-356, 2004
  pubmed

• 3) Dettmers C, Teske U, Hamzei F et al : Distributed form of constraint-induced movement therapy improves functional outcome and quality of life after stroke. Arch Phys Med Rehabili 86 : 204-209, 2005

• 4) Dobkin BH : Strategies for stroke rehabilitation. Lancet Neurol 3 : 528-536, 2004
  pubmed

• 5) Page SJ, Levine P, Leonard AC : Effects of mental practice on affectedlimb use and function in chronic stroke. Arch Phys Med Rehabili 86 : 399-402, 2005

• 6) Yan T, Hui-Chan CW, Li LS : Functional electrical stimulation improves motor recovery of the lower extremity and walking ability of subjects with first acute stroke : a randomized placebo-controlled trial. Stroke 36 : 80-85, 2005
  pubmed

• 7) Sullivan KJ, Knowlton BJ, Dobkin BH : Step training with body weight support : effect of treadmill speed and practice paradigms on poststroke locomotor recovery. Arch Phys Med Rehabili 83 : 683-691, 2002

Chapter7 EBM

P.394 掲載の参考文献

• 1) Dahlof B, Devereux RB, KjeldsenSE et al : Cardiovascular Morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) : a randomised trial against atenolol. Lancet 359 : 995-1003, 2002
  pubmed

• 2) ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major Outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 : 2981-2997, 2002
  pubmed

• 3) Julius S, Kjeldsen SE, Weber M et al : Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine : the VALUE randomised trial. Lancet 363 : 2022-2031, 2004

• 4) Lithell H, Hansson L, Skoog I et al : The study on Cognition and Prognosis in the Elderly (SCOPE) : principal results of a randomized double-blind intervention trial. J Hypertens 21 : 875-886, 2003

• 5) PROGRESS Collaborative Group : Randomisedtrial of a perindopril-based blood-pressure-lowering regimen among 6, 105 individuals with previous stroke or transient ischaemic attack. Lancet 358 : 1033-1041, 2001
  pubmed

• 6) Schrader J, Luders S, Kulschewski A et al : The ACCESS Study : Evaluation of Acute Candesartan Cilexetil Therapyin Stroke Survivors. Stroke 34 : 1699-1703, 2003

P.399 掲載の参考文献

• 1) International Stroke Trial Collaborative Group : The International Stroke Trial (IST) : a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 : 1569-1581, 1997
  pubmed

• 2) CAST (Chinese Acute Stroke Trial) Collaborative Group : CAST : randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349 : 1641-1649, 1997

• 3) Chen ZM, Sandercock P, Pan HC et al : Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 31 : 1240-1249, 2000

• 4) Antiplatelet Trialists'Collaboration : Collaborative overview of randomised trials of antiplatelet therapy-I : Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 : 81-106, 1994
  pubmed

• 5) Antithrombotic Trialists'Collaboration : Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71-86, 2002
  pubmed

• 6) Garcia Rodriguez LA, Hernandez-Diaz S, de Abajo FJ : Association between aspirin and upper gastrointestinal complications : systematic review of epidemiologic studies. Br J Clin Pharmacol 52 : 563-571, 2001
  pubmed

• 7) van Walraven C, Hart RG, Singer DE et al : Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation : an individual patient meta-analysis. JAMA 288 : 2441-2448, 2002
  pubmed

P.407 掲載の参考文献

• 1) Law MR, Wald NJ, Rudnicka AR : Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke : systematic review and meta-analysis. BMJ 326 : 1423, 2003
  pubmed

• 2) Eastern Stroke and Coronary Heart Disease Collaborative Research Group : Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 352 : 1801-1807, 1998

• 3) Pedersen TR, Kjekshus J, Pyorala K et al : Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81 : 333-335, 1998
  pubmed

• 4) Plehn JF, Davis BR, Sacks FM et al : Reduction of stroke incidence after myocardial infarction with pravastatin : the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation 99 : 216-223, 1999

• 5) White HD, Simes RJ, Anderson NE et al : Pravastatin therapy and the risk of stroke. N Engl J Med 343 : 317-326, 2000
  pubmed

• 6) 野村栄一, 郡山達男, 松本昌泰 : 脳卒中の予防にスタチンは有効か. EBMジャーナル 6 : 602-606, 2005
  Medical*Online

• 7) Amarenco P, Labreuche J, Lavallee P et al : Statins in stroke prevention and carotid atherosclerosis : systematic review and up-to-date meta-analysis. Stroke 35 : 2902-2909, 2004
  pubmed

• 8) Briel M, Studer M, Glass TR et al : Effects of statins on stroke prevention in patients with and without coronary heart disease : a meta-analysis of r andomized controlled trials. Am J Med 117 : 596-606, 2004

• 9) Liao JK : Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96 (5A) : 24F-33F, 2005
  pubmed

• 10) Amarenco P, Bogousslavsky J, Callahan AS et al : Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 16 : 389-395, 2003
  pubmed

• 11) 松本昌泰 : 脳血管疾患の再発に対する高脂血症治療薬のHMGCoA阻害剤の予防効果に関する研究. 厚生労働科学研究費補助金 (循環器疾患等総合研究事業) 平成14-16年度総合研究報告書, 2005

• 12) 松本昌泰, 野村栄一, 郡山達男 : スタチン療法の意義 : J-STARSを中心に. 脳卒中 26 : 651-655, 2004
  Medical*Online

P.411 掲載の参考文献

• 1) The EC/IC Bypass Study Group : Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of aninternational randomized trial. N Engl J Med 313 : 1191-1200, 1985

P.415 掲載の参考文献

• 1) Langhorne P, Williams BO, Gilchrist W et al : Do stroke units save lives? Lancet 342 : 395-398, 1993
  pubmed

• 2) Jorgensen HS, Nakayama H, Raaschou HO et al : The effect of a stroke unit : reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 26 : 1178-1182, 1995

• 3) Stroke Unit Trialists'Collaboration : How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 28 : 2139-2144, 1997
  pubmed

• 4) Indredavik B, Bakke F, Slordahl SA et al : Stroke unit treatment. 10-year follow-up. Stroke 30 : 1524-1527, 1999
  pubmed

• 5) Jorgensen HS, Kammersgaard LP, Nakayama H et al : Treatment and rehabilitation on a stroke unit improves 5-yearsurvival. A community-based study. Stroke 30 : 930-933, 1999

• 6) Langhorne P, Williams BO, Gilchrist W et al : A formal overview of stroke unit trials. Rev Neurol 23 : 394-398, 1995
  pubmed

• 7) Indredavik B, Bakke F, Slordahl SA et al : Stroke unit treatment improves long-term quality of life : a randomized controlled trial. Stroke 29 : 895-899, 1998
  pubmed

Chapter8 脳卒中治療ガイドライン2004のポイント

P.420 掲載の参考文献

• 1) 日本脳卒中治療ガイドライン2004 Web版 : http://www.jsts.gr.jp/jss08.html

• 2) Adams HP, Adams RJ, Brott T et al : Guidelines for the Early Management of Patients With Ischemic Stroke. A Scientific Statement From the Stroke Council of the American Stroke Association. Stroke 30 : 905-915, 1999

P.430 掲載の参考文献

• 1) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004

• 2) Adams HP Jr, Adams RJ, Brott T et al : Guideline for the early management of patients with ischemic stroke. A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 : 1056-1083, 2003
  pubmed

• 3) Wolf PA, Clagett GP, Easton JD et al : Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 30 : 1991-1994, 1999
  pubmed

P.435 掲載の参考文献

• 1) Kanaya H, Saiki I, Ohuchi T et al : Hypertensive Intracerebral Hemorrhage in Japan : Update on Surgical Treatment. Hypertensive Intracerebral Hemorrhage, Raven Press, New York, 1983, p.147-163

• 2) 金谷春之 : 高血圧性脳出血の治療の現況-全国調査の成績より. 脳卒中 12 : 509-524 1990

• 3) Broderick JP, Adams HP Jr, Barsain W et al : Guideline for the management of spontaneous intracerebral hemorrhage? A statement for the healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke 30 : 905-915, 1999

• 4) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 2004, p.96-139

P.441 掲載の参考文献

• 1) 吉峰俊樹編 : 科学的根拠に基づくクモ膜下出血診療ガイドライン, 日本脳卒中の外科学会, 2003

• 2) 日本脳卒中の外科学会監 (日本脳卒中の外科学会クモ膜下出血診療ガイドライン改訂委員会編) : EBMに基づくクモ膜下出血診療ガイドライン, じほう, 東京, 2004

• 3) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004

• 4) Mayberg MR, Batjer HH, Dacey R et al : Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25 : 2315-2328, 1994
  pubmed

• 5) Johnston SC, Higashida RT, Barrow DL et al : Recommendations for the endovascular treatment of intracranial aneurysms : a statement for healthcare professionals from the committee on cerebrovascular Imaging of the American Heart Association Councilon Cardiovascular Radiology. Stroke 33 : 2536-2544, 2002

• 6) Molyneux A, Kerr, R, Stratton I et al : International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group : International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms : a randolnised trial. Lancet 360 : 1267-1274, 2002

• 7) Molyneux AJ, Kerr RS, Yu LM et al : International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms : a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366 : 809-817, 2005
  pubmed

P.445 掲載の参考文献

• 1) Agency for Health Care Policy and Research US Department of Health and Human Services : clinical practice guideline No.16, Rockville, MD, 1995

• 2) Herbert R, Moseley A, Sherrington C : PEDro : a database of randomised controlled trials in physiotherapy. Health Inf Manag 28 : 186-188, 1999 (http://www.pedro.fhs.usyd.edu.au/index.html)

Chapter9 治療に関するQ&A

P.450 掲載の参考文献

• 1) 篠原幸人, 吉本高志, 福内靖男ほか : 脳卒中治療ガイドライン2004 (脳卒中合同ガイドライン委員会編), 協和企画, 東京, 2004

• 2) 日本高血圧学会高血圧治療ガイドライン作成委員会 : 高血圧治療ガイドライン2004, ライフサイエンス出版, 東京, 2004

• 3) Adams HP Jr, Adams RJ, Brott T et al : Guidelines for the early management of patients with ischemic stroke : A scientific statement from the Stroke Council of the American Stroke Association. Strok 34 : 1056-1083, 2003

• 4) Broderick JP, Adams HP Jr, Barsan W et al : Guidelines for the management of spontaneous intracerebral hemorrhage : A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30 : 905-915, 1999
  pubmed

• 5) Ahmed N, Nasman P, Wahlgren NG : Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 31 : 1250-1255, 2000
  pubmed

• 6) Schrader J, Luders S, Kulschewski A et al : The ACCESS Study : evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 34 : 1699-1703, 2003
  pubmed

• 7) Hashimoto H, Kuriyama Y, Imakita S et al : J Stroke Cerebrovasc Dis 6 : 319-324, 1997
  pubmed

• 8) Kazui S, Naritomi H, Yamamoto H et al : Enlargement of spontaneous Intracerebral Hemorrhage. Incidence and time course. Stroke 27 : 1783-1787, 1996
  pubmed

• 9) Meyer JS, Bauer RB : Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs. Neurology 12 : 36-47, 1962
  pubmed

P.455 掲載の参考文献

• 1) Pitt B, Byington RP, Furberg CD et al : Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 102 : 1503-1510, 2000
  pubmed

• 2) Forette F, Seux ML, Staessen JA et al : The prevention of dementia with antihypertensive treatment : new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Ann Intern Med 162 : 2046-2052, 2002

• 3) Forette F, Seux ML, Staessen JA et al : Prevention of dementia in rand omised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 : 1347-1351, 1998

• 4) PROGRESS collaborative group : Randomised trial of perindoprilbased blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 : 1033-1041, 2001
  pubmed

• 5) Yusuf S, Sleight P, Pogue J et al : Effects of anangiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 : 145-153, 2000

• 6) Pfeffer MA, Swedberg K, Granger CB et al : Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM-Overall programme. Lancet 362 : 759-766, 2003
  pubmed

• 7) Jafar TH, Schmid CH, Landa M et al : Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135 : 73-87, 2001
  pubmed

• 8) Viberti G, Wheeldon NM : Micro Albuminuria Reduction With VALsartan (MARVAL) Study Investigators : Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus : a blood pressure-independent effect. Circulation 106 : 672-678, 2002

• 9) Ohkubo T, Chapman N, Neal B et al : Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 169 : 1041-1045, 2004
  pubmed

• 10) Lithell H, Hansson L, Skoog I et al : The Study on Cognition and Prognosis in the Elderly (SCOPE) : principal results of a randomized double-blind intervention trial. J Hypertens 21 : 875-886, 2003

P.459 掲載の参考文献

• 1) van Kooten F, Hoogerbrugge N, Naarding P et al : Hyperglycemia in the acute phase of stroke is not caused by stress. Stroke 24 : 1129-1132, 1993

• 2) Weir CJ, Murray GD, Dyker AG et al : Is hyperglycemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314 : 1303-1306, 1997
  pubmed

• 3) Capes SE, Hunt D, Malmberg K et al : Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients : a systematic overview. Stroke 32 : 2426-2432, 2001
  pubmed

• 4) Bruno A, Levine SR, Frankel MR et al : Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59 : 669-674, 2002
  pubmed

• 5) Baird TA, Parsons MW, Phanh T et al : Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34 : 2208-2214, 2003

• 6) Parsons MW, Barber PA, Desmond PM et al : Acute hyperglycemia adversely affects stroke outcome : a magnetic resonance imaging and spectroscopy study. Ann Neurol 52 : 20-28, 2002
  pubmed

• 7) Scott JF, Robinson GM, French JM et al : Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia : the Glucose Insulin in Stroke Trial (GIST). Stroke 30 : 793-799, 1999
  pubmed

• 8) Adams HP Jr, Adams RJ, Brott T et al : Guidelines for the early management of patients with ischemic stroke : A scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 : 1056-1083, 2003
  pubmed

• 9) Hack W, Kaste M, Bogousslavsky J et al;European Stroke Initiative Executive Committee and the EUSI Writing Committee : European Stroke Initiative recommendations for Stroke Management-update 2003. Cerebrovasc Dis 16 : 311-337, 2003

P.461 掲載の参考文献

• 1) 日本透析医学会統計調査委員会 : わが国の慢性透析療法の現況 (2002年12月31日現在). 日本透析医学会雑誌 37 : 1-24, 2004

• 2) 平方秀樹 : 透析患者の脳血管障害に関する研究. 平成8年度厚生科学研究費補助金, 長期慢性疾患総合研究事業 (慢性腎不全) 研究報告書. 49-54, 1997

• 3) Iseki K, Kinjo K, Kimnra Y et al : Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney int 44 : 1086-1090, 1993

• 4) 柏木史彦, 片山泰朗 : 高張溶液 (glycerol) の実験的脳虚血に及ぼす効果-Part1. 過酸化脂質, prostaglandins, 脳浮腫および脳代謝の検討. 脳神経 40 : 190-216, 1988

• 5) Krane NK : Intracranial pressure measurement in a patient undergoing hemodialysis and peritoneal dialysis. Am J Kidney Dis 13 : 336-339, 1989

• 6) Davenport A, Bramley PN : Cerebral function analyzing monitor and visual evoked potentials as a noninvasive method of detecting cerebral dysfunction in patients with acute hepatic and renalfailure treated with intermittent machine hemofiltration. Ren Fail 15 : 515-522, 1993

P.466 掲載の参考文献

• 1) Feinberg WM, Blackshear JL, Laupacis A et al : Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155 : 469-473, 1995
  pubmed

• 2) Jorgensen HS, Nakayama H, Reith J et al : Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke 27 : 1765-1769, 1996
  pubmed

• 3) Sandercock P, Bamford J, Dennis M et al : Atrial fibrillation and stroke : prevalence in different types of stroke and influence on early and long term prognosis. (Oxfordshire Community Stroke Project) BMJ 305 : 1460-1465, 1992
  pubmed

• 4) AsplundK, Carlberg B, Sundstrom G : Stroke in the elderly. Cerebrovasc Dis 2 : 152-157, 1992

• 5) Wolf PA, Abbott RD, Kannel WB : Atrial fibrillation as an independent risk factor for stroke : The Framingham Study. Stroke 22 : 983-988, 1991
  pubmed

• 6) Hart RG, Halperin JL : Atrial fibrillation and thromboembolism : a decade of progress in stroke prevention. Ann Intern Med 131 : 688-695, 1999
  pubmed

• 7) Hart RG, Benavente O, McBrlde R et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation : a meta-analysis. Ann Intern Med 131 : 492-501, 1999

• 8) Fang MC, Chang Y, Hylek EM et al : Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141 : 745-752, 2004
  pubmed

• 9) Fuster V, Ryden LE, Asinger RW et al : ACC/AHA/ESC guidelines for themanagement of patients with atrial fibrillation : executive summary. A report of the American College of Cardiology/American Heart Association Task Forceon Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38 : 1231-1265, 2001

• 10) Hart RG, Sherman DG, Easton JD et al : Prevention of stroke in patients with nonvalvular atrial fibrillation. Neurology 51 : 674-681, 1998
  pubmed

• 11) Yamaguchi T : Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 31 : 817-821, 2000

• 12) Hylek EM, Go AS, Chang Y et al : Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349 : 1019-1026, 2003
  pubmed

• 13) Brass LM, Krumholz HM, Scinto JM et al : Warfarin use among patients with atrial fibrillation. Stroke 28 : 2382-2389, 1997
  pubmed

P.472 掲載の参考文献

• 1) Hart RG, Benavente O, McBride R et al : Antithrombotic therapy to prevent stroke in patients with atrial fibrillation : a meta-analysis. Ann Intern Med 131 : 492-501, 1999
  pubmed

• 2) Antithrombotic Trialist's Collaboration : Collaborate meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71-86, 2002

• 3) Takano K, Yamaguchi T, Minematsu K et al : Defferences in clinical features and computed tomographic findings between embolic and non-embolic acute ischemic stroke : a quantitative differential diagnosis. Intern Med 37 : 141-148, 1998

• 4) 高野健太郎 : 血液凝固亢進のメカニズム : 凝固・線溶活性化. 脳血管障害の治療 (矢崎義雄編), 現代医療社, 東京, 1999, p.211-220

• 5) Takano K, Yamaguchi T, Okada Y et al : Hypercoagulability in acute ischemic stroke : Analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method. Thromb Res 58 : 481-491, 1990
  pubmed

• 6) Yasaka M, Miyatake K, Mitani M et al : Intracardiac mobile thrombus and D-dimer fragment of fibrininpatients with mitralstenosis. Br Heart J 66 : 22-25, 1991

• 7) Takano K, Yamaguchi T, Kato H et al : Activation of coagulation in acute cardioembolic stroke. Stroke 22 : 12-16, 1991
  pubmed

• 8) Takano K, Yamaguchi T, Uchida K : Markers of a hypercoagulable state following acute ischemic stroke. Stroke 23 : 194-198, 1992
  pubmed

• 9) Yamazaki M, Uchiyama S, Maruyama S : Alterations of haemostatic markers in various subtypes and phases of stroke. Blood Coagl Fibrinolysis 4 : 707-712, 1993
  pubmed

• 10) van Wersch JW, van Mourik-Alderliesten CH, Coremans A : Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation. Blood Coagl Fibrinolysis 3 : 183-186, 1992
  pubmed

• 11) Takano K, Iino K, Ibayashi S et al : Hypercoagulable state under low-intensity warfarin anticoagulation assessed with hemostatic markers in cardiac disorders. Am J Cardiol 74 : 935-939, 1994
  pubmed

P.477 掲載の参考文献

• 1) Ardekian L, Gaspar R, Peled M et al : Does low-dose aspirin therapy complicate oral surgical procedures? J Am Dent Assoc 131 : 331-335, 2000
  pubmed

• 2) Little JW, Miller CS, Henry RG et al : Antithrombotic agents : implications in dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93 : 544-551, 2002
  pubmed

• 3) Tamai Y, Takami H, Nakahata R et al : Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus. Haemostasis 29 : 269-276, 1999
  pubmed

• 4) Wahl MJ : Dental surgery in anticoagulated patients. Arch Intern Med 158 : 1610-1616, 1998
  pubmed

• 5) Evans IL, Sayers MS, Gibbons AJ et al : Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxillofac Surg 40 : 248-252, 2002
  pubmed

• 6) Yasaka M, Minematsu K, Yamaguchi T : Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40 : 1183-1188, 2001
  pubmed

• 7) 矢坂正弘, 峰松一夫, 木村和美ほか : 抜歯時のワルファリン管理に関するアンケート調査. 日本醫事新報 4124 : 21-25, 2003
  Medical*Online

• 8) 矢坂正弘 : 抜歯時のワルファリン管理, 中止か?継続か? 医学のあゆみ 207 : 941-942, 2003
  Medical*Online

• 9) Kearon C, Hirsh J : Management of anticoagulation before and after elective surgery. N Engl J Med 336 : 1506-1511, 1997
  pubmed

• 10) Kearon C, Hirsh J : Perioperative management of patients receiving oral anticoagulants. Arch Intern Med 163 : 2532-2533, 2003
  pubmed

P.481 掲載の参考文献

• 1) 澤田徹, 種田二郎, 岡本幸市ほか : 無症候性脳血管障害の診断基準に関する研究. 脳卒中 19 : 489-493, 1998

• 2) Vermeer SE, Hollander M, van Dijk EJ et al : Silent brain infarcts and white matter lesions increase stroke risk in the general population : the Rotterdam Scan Study. Stroke 34 : 1126-1129, 2003
  pubmed

• 3) Kobayashi S, Okada K, Koide H et al : Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 28 : 1932-1939, 1997
  pubmed

• 4) Yamaguchi T, Nishimura K, Minematsu K : Benefits and hazards of antiplatelet therapy in ischemic cerebrovascular diseases. 脈管学 34 : 279-285, 1994

• 5) Kato H, Izumiyama M, Izumiyama K et al : Silent cerebral microbleeds on T2＊-weighted MRI : correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 33 : 1536-1540, 2002
  pubmed

P.487 掲載の参考文献

• 1) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004

• 2) Antiplatelet Trialists'Collaboration : Collaborative overview of randomised trials of antiplatelet therapy-I : Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 : 81-106, 1994
  pubmed

• 3) Antithrombotic Trialists'Collaboration : Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 : 71-86, 2002
  pubmed

• 4) Jimenez AH, Stubbs ME, Tofler GH et al : Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. Am J Cardiol 69 : 258-262, 1992
  pubmed

• 5) He J, Whelton PK, Vu B et al : Aspirin and risk of hemorrhagic stroke : a meta-analysis of randomized controlled trials. JAMA 280 : 1930-1935, 1998
  pubmed

• 6) 永山正雄 : CAPRIE. 血栓症ナビゲーター, メディカルレビュー社, 東京, 2005, p.282-283

• 7) CAPRIE Steering Committee : A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 : 1329-1339, 1996

• 8) Hankey GJ, Sudlow CL, Dunbabin DW : Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients (Cochrane Review) ;in : The Cochrane Library. Oxford, Update Software, 2003, issue 3.

• 9) Ringleb PA, Bhatt DL, Hirsch AT et al;Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events Investigators : Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke 35 : 528-532, 2004
  pubmed

• 10) Creager MA : Results of the CAPRIE trial : efficacy and safety of clopidogrel. Clopidogrel versus aspirin in patients at risk of ischaemic events. Vasc Med 3 : 257-260, 1998
  pubmed

• 11) Diener HC, Cunha L, Forbes C et al : European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 : 1-13, 1996
  pubmed

• 12) Urbano LA, Bogousslavsky J : Antiplatelet drugs in ischemic stroke prevention : from monotherapy to combined treatment. Cerebrovasc Dis 17 (Suppl. 1) : 74-80, 2004

• 13) Sacco RL, Sivenius J, Diener HC : Efficacy of aspirin plus extendedrelease dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol 62 : 403-408, 2005
  pubmed

• 14) Gotoh F, Tohgi H, Hirai S et al : Cilostazol stroke prevention study : a placebo-cintrolled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 9 : 147-157, 2000
  pubmed

• 15) Kwon SU, Cho YJ, Koo JS et al : Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis : the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 36 : 782-786, 2005
  pubmed

• 16) Bradley BC, Perdue KS, Tisdel KA et al : Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center. Am J Cardiol 85 : 568-572, 2000

• 17) Albers GW, Amarenco P, Easton JD et al : Antithrombotic and thrombolytic therapy for ischemic stroke : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (3 Suppl. ) : 483S-512S, 2004

P.494 掲載の参考文献

• 1) 棚橋紀夫, 福内靖男 : 抗血栓療法. 現在医療 35 (増刊I) : 485-491, 2003

• 2) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004, p.1-234

• 3) Fisher CM : Lacunar strokes and infarcts : a review. Neurology 32 : 871-876, 1982
  pubmed

• 4) 内山真一郎 : 虚血後の血栓形成・凝固亢進. 脳と循環 8 : 123-129, 2003
  Medical*Online

• 5) Caplan LR. : Intracranial branch atheromatous disease : a neglected, understudied, and underused concept. Neurology39 : 1246-1250, 1989
  pubmed

• 6) 山本康正, 大岩海陽, 林正道ほか : ラクナ梗塞における凝固・線溶活性-lipohyalinosis型小径ラクナとアテローム型大径ラクナの差異. 臨床神経 39 : 1104-1108, 1999

• 7) 大友英一, 沓沢尚之, 小暮久也ほか : 脳血栓症急性期におけるOKY-046の臨床的有用性. -プラセボを対照とした多施設二重盲検試験-. 臨床医薬 7 : 353-388, 1991
  Medical*Online

• 8) 篠原幸人, 北川泰人, 入交昭一郎ほか : 脳血栓症急性期に対するオザグレルナトリウムの臨床評価-NIH Stroke ScaleおよびBarthel indexを用いた検討. 臨床成人病 26 : 771-780, 1996

• 9) 田崎義昭, 小林祥泰, 東儀英夫ほか : 脳血栓症急性期に対する抗トロンビン薬MD805の臨床的有用性. プラセボを対照とした多施設二重盲検群間比較試験. 医学のあゆみ 161 : 887-907, 1992

• 10) 福内靖男, 東儀英夫, 篠原幸人ほか : 脳血栓症急性期におけるargatrobanの効果-sodiumozagrelとの比較臨床試験-. 神経治療 18 : 273-282, 2001

P.499 掲載の参考文献

• 1) 岡田靖 : 脳梗塞急性期の内科的治療. リハビリテーションMOOK (千野直一, 安藤徳彦編) 金原出版, 東京, 1999, p.42-50

• 2) 蜂須賀研二 : 脳卒中急性期のリハビリテーション. Medicina 34 : 2388-2389, 1997

• 3) 出江紳一, 長谷公隆 : 脳卒中急性期のリハビリテーション. リハビリテーションMOOK2 (千野直一, 安藤徳彦編), 金原出版, 東京, p.58-73, 2001

• 4) Anderson TP : Management of completed stroke. J Okla State Med Assoc 63 : 403-411, 1970
  pubmed

• 5) 三好正堂, 石神重信 : 急性期はリハのゴールデンタイム. 臨床リハ 13 : 32-40, 2004

• 6) 奈良聡一郎, 渡邊哲郎, 蜂須賀研二 : 脳血管障害のリハビリテーション (急性期・慢性期). 神経内科 58 (Suppl. 3) : 598-604, 2003

• 7) 藤島一郎, 高橋博達, 醇克良ほか : 嚥下障害のスクリーニングテスト. 臨床リハ 11 : 790-796, 2002

P.503 掲載の参考文献

• 1) 脳卒中合同ガイドライン委員会 : 脳卒中治療ガイドライン2004 (篠原幸人, 吉本高志, 福内靖男ほか編), 協和企画, 東京, 2004, p.27

• 2) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study : Endarterectomy for Asymptomatic Carotid Stenosis. JAMA 273 : 1421-1428, 1995
  pubmed

• 3) Asymptomatic Carotid Stenosis and Risk of Stroke Study (ACSRS) ongoing study. http://www.i.u.angiology.org/anglais/work-group/acsrs-gb.htm

• 4) Halliday A, Mansfield A, MarroJ et al;MRC Asymptomatic carotid Surgery Trial (ACST) Collaborative Group : Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms : randomised controlled trial. Lancet 363 : 1491-1502, 2004

• 5) Yadav JS, Wholey MH, Kuntz RE et al : Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 : 1493-1501, 2004
  pubmed

P.508 掲載の参考文献

• 1) 中央社会保険医療協議会診療報酬調査専門組織・DPC評価分科会 : 平成16年度DPC導入の影響評価のための調査について (資料). 厚生労働省保険局医療課, 2005

• 2) 松田晋哉 : 病院における包括払い制の現状と課題. 社会保障研究 39 : 130-143, 2003

• 3) 康永秀生, 井出博生, 今村知明ほか : DPC制度導入は在院日数短縮のインセンティブとなるか. 病院管理 41 : 115-127, 2004

• 4) 武藤正樹 : クリティカルパスの地域への展開. 実験治療 675 : 139-143, 2004

• 5) 武藤正樹 : 医療制度改革とクリティカルパス. 日本医事新報 4163 : 73-80, 2004

• 6) 東口高志 : NSTの今日的意義. 医薬ジャーナル 40 : 3233-3240, 2004

• 7) 原祐一 : DRG/PPSの功罪. 日本医事新報 4054 : 109-112, 2002

• 8) 後藤伸之, 政田幹夫 : 後発薬品の現状と将来-医薬品情報を評価・提供する立場から. 医薬ジャーナル 9 : 2979-2987, 2003

P.515 掲載の参考文献

• 1) Fujiwara K, Date I, Shingo T et al : Reduction of infarctvolume and apoptosis by grafting of encapsulated basic fibroblast growth factor-secreting cells in a model of middle cerebral artery occlusion in rats. J Neurosurg 99 : 1053-1062, 2003

• 2) Yano A, Shingo T, Takeuchi A et al : encapsulated vascular endothelial growth factor-secreting cell grafs have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg 103 : 104-114, 2005

• 3) Sinden JD, Rashid-Doubell F, Kershaw TR et al : Recovery of spatial learning by grafts of a conditionally immortalized hippocampal neuroepithelial cell line into the ischaemia-lesioned hippocampus. Neuroscience 81 : 599-608, 1997
  pubmed

• 4) Nakatomi H, Kuriu T, Okabe S et al : Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110 : 429-441, 2002
  pubmed

• 5) Jiang Y, Jahagirdar BN, Reinhardt RL et al : Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 : 41-49, 2002
  pubmed

• 6) Li Y, Chen J, Wang L et al : Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56 : 1666-1672, 2001

• 7) Chen J, Li Y, Wang L et al : Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 : 1005-1011, 2001

• 8) Hoehn M, Kustermann E, Blunk J et al : Monitoring of implanted stem cell migration in vivo : a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci USA 99 : 16267-16272, 2002
  pubmed

• 9) Borlongan CV, Tajima Y, Trojanowski JQ et al : Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats. Exp Neurol 149 : 310-321, 1998
  pubmed

• 10) Meltzer CC, Kondziolka D, Villemagne VL et al : Serial［18F］fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery 49 : 586-591, 2001
  pubmed

P.523 掲載の参考文献

• 1) Aras MD, Gokkaya NK, Comert D et al : Shoulder pain in hemiplegia : results from a national rehabilitation hospital in Turkey. Am J Phys Med Rehabil 83 : 713-719, 2004

• 2) Boivie J, Leijon G : Pain and altered sensation in patients with central post-stroke pain. In : Altered sensation and pain, recent achievements in restorative neurology (Dimitrijevic M, Wall PD, Lindblom U eds. Karger, Basel, 1990, p.42-55

• 3) Wiffen P, Collins S, McQuay H et al : Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev Jul 20 : (3) : CD001133, 2005
  pubmed

• 4) Shimodozono M, Kawahira K, Kamishita T : Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. Int J Neurosci 112 : 1173-1181, 2002
  pubmed

• 5) Nicholson BD : Evaluation and treatment of central pain syndromes. Neurology 62 (Suppl 2) : S30-36, 2004

• 6) Gonzales GR : Central pain : diagnosis and treatment strategies. Neurology 45 (Suppl 9) : S11-S16, 1995

• 7) Costa JL, Wetzel FT : 慢性疼痛14章. 神経リハビリテーション (Lazer RB ed. 岩崎祐三ほか訳), 医学書院, 東京, 1998, p.198-210

P.526 掲載の参考文献

• 1) Kannel WB, Abbott RD, Savage DD et al : Epidemiologic features of chronic atrial fibriUation : the Framingham Study. N Engl J Med 306 : 1018-1022, 1982
  pubmed

• 2) Cerebral Embolism Task Force : Cardiogenic brain embolism. Arch Neurol 43 : 71-84, 1986
  pubmed

• 3) Cerebral Embolism Task Force. Cardiogenic brain embolism. Second report of the Cerebral Embolism Task Force. Arch Neurol 46 : 727-743, 1989
  pubmed

• 4) Streifler JY, Furlan AJ, Barnett HJM : Cardiogenic brain embolism;incidence, varieties, treatment. In : Stroke : pathophysiology, diagnosis, and management. 2nd ed. (Barnett HJM, Stein BM, Morh JP et al eds). Churchill Livingstone, New York, 1992, p.967-994

• 5) Wijffels MC, Kirchhof CJ, Dorland R et al : Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92 : 1954-1968, 1995
  pubmed

• 6) Nakashima H, Kumagai K, Urata H et al : Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101 : 2612-2617, 2000
  pubmed

• 7) Kumagai K, Nakashima H, Urata H et al : Effects of Angiotensin II type 1 receptor antagonist on electrical and structural remodeling inatrial fibrillation. J Am Coll Cardiol 41 : 2197-2204, 2003